M&A Deal Summary

Bausch Health Acquires Ortho Dermatologics

On July 15, 2011, Bausch Health acquired consumer products company Ortho Dermatologics from Janssen Pharmaceuticals for 345M USD

Acquisition Highlights
  • This is Bausch Health’s 3rd transaction in the Consumer Products sector.
  • This is Bausch Health’s 12th largest (disclosed) transaction.
  • This is Bausch Health’s 6th transaction in the United States.
  • This is Bausch Health’s 3rd transaction in New Jersey.

M&A Deal Summary
Date 2011-07-15
Target Ortho Dermatologics
Sector Consumer Products
Buyer(s) Bausch Health
Sellers(s) Janssen Pharmaceuticals
Deal Type Divestiture
Deal Value 345M USD

Target

Ortho Dermatologics

Skillman, New Jersey, United States
Ortho Dermatologics, Inc. is a provider of dermatologist recommended and prescribed skincare products RETIN-A MICRO, ERTACZO, and RENOVA.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada
Category Company
Sector Life Science
Employees20,270
Revenue 8.8B USD (2023)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.

DEAL STATS #
Overall 13 of 35
Sector (Consumer Products) 3 of 6
Type (Divestiture) 5 of 9
State (New Jersey) 3 of 5
Country (United States) 6 of 22
Year (2011) 5 of 7
Size (of disclosed) 12 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-07-11 Dermik Laboratories

Bridgewater, New Jersey, United States

Dermik Laboratories, Inc. portfolio includes major therapeutic and aesthetic dermatology brands such as Benzaclin® for the treatment of acne, Carac® for the treatment of keratoses and Sculptra®, a facial injectable for the correction of facial wrinkles and folds.

Buy $425M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-08-19 Sanitas AB

Kaunas, Lithuania

Sanitas AB is a branded generic pharmaceutical company focused on specialty therapeutic segments. Company are vertically integrated across formulation development, registration, manufacturing and sales and marketing.

Buy -

Seller(S) 1

SELLER

Janssen Pharmaceuticals

Titusville, New Jersey, United States
Category Company
Founded 1973
Sector Life Science
DESCRIPTION

Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson & Johnson, provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.

DEAL STATS #
Overall 2 of 3
Sector (Consumer Products) 1 of 2
Type (Divestiture) 2 of 3
State (New Jersey) 1 of 1
Country (United States) 1 of 2
Year (2011) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-14 Janssen Pharmaceuticals - Animal Health Business

Beerse, Belgium

Janssen Pharmaceuticals - Animal Health Business is primarily European-focused, targeting disease segments in companion animals and livestock, with special emphasis on swine and poultry.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-11-20 INCIVO

United States

INCIVO is a prescription medicine used with the medicines peginterferon alfa and ribavirin to treat chronic (lasting a long time) hepatitis C genotype 1 infection in adults with stable liver problems, who have not been treated before or who have failed previous treatment.

Buy $152M
Mergr

Product

Company

Legal